|
US7276497B2
(en)
*
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
EP1789391B1
(en)
|
2004-07-23 |
2017-06-28 |
Endocyte, Inc. |
Bivalent linkers and conjugates thereof
|
|
WO2007024536A2
(en)
|
2005-08-24 |
2007-03-01 |
Immunogen, Inc. |
Process for preparing maytansinoid antibody conjugates
|
|
CA2680535C
(en)
|
2007-03-14 |
2016-09-20 |
Endocyte, Inc. |
Binding ligand linked drug delivery conjugates of tubulysins
|
|
BRPI0809435A2
(pt)
|
2007-03-27 |
2014-09-09 |
Sea Lane Biotechnologies, Llc |
Constructos e bibliotecas que compreendem sequências de cadeia leve substituida de anticorpos
|
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
|
CA2690943A1
(en)
|
2007-06-25 |
2008-12-31 |
Endocyte, Inc. |
Conjugates containing hydrophilic spacer linkers
|
|
SG189817A1
(en)
|
2008-04-30 |
2013-05-31 |
Immunogen Inc |
Potent conjugates and hydrophilic linkers
|
|
KR20230003298A
(ko)
|
2008-04-30 |
2023-01-05 |
이뮤노젠 아이엔씨 |
가교제 및 그 용도
|
|
CN102482345A
(zh)
|
2009-05-13 |
2012-05-30 |
航道生物技术有限责任公司 |
针对流感病毒的中和分子
|
|
SG176068A1
(en)
*
|
2009-06-03 |
2011-12-29 |
Immunogen Inc |
Conjugation methods
|
|
AU2015201534B2
(en)
*
|
2009-06-03 |
2016-11-24 |
Immunogen, Inc. |
Conjugation methods
|
|
FR2947269B1
(fr)
|
2009-06-29 |
2013-01-18 |
Sanofi Aventis |
Nouveaux composes anticancereux
|
|
FR2949469A1
(fr)
*
|
2009-08-25 |
2011-03-04 |
Sanofi Aventis |
Derives anticancereux, leur preparation et leur application en therapeutique
|
|
AU2010292172A1
(en)
|
2009-09-09 |
2012-05-03 |
Centrose, Llc |
Extracellular targeted drug conjugates
|
|
TW201117814A
(en)
*
|
2009-10-02 |
2011-06-01 |
Sanofi Aventis |
New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody
|
|
EP2486023A4
(en)
*
|
2009-10-06 |
2014-05-07 |
Immunogen Inc |
EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
|
|
RS55738B1
(sr)
|
2010-02-24 |
2017-07-31 |
Immunogen Inc |
Imunokonjugati protiv folatnog receptora 1 i njihove upotrebe
|
|
EP3620467A1
(en)
|
2010-03-12 |
2020-03-11 |
Debiopharm International SA |
Cd37-binding molecules and immunoconjugates thereof
|
|
FR2963007B1
(fr)
|
2010-07-26 |
2013-04-05 |
Sanofi Aventis |
Derives anticancereux, leur preparation et leur application therapeutique
|
|
WO2012019024A2
(en)
|
2010-08-04 |
2012-02-09 |
Immunogen, Inc. |
Her3-binding molecules and immunoconjugates thereof
|
|
TW201302793A
(zh)
|
2010-09-03 |
2013-01-16 |
Glaxo Group Ltd |
新穎之抗原結合蛋白
|
|
EA201390575A1
(ru)
|
2010-10-29 |
2014-01-30 |
Иммьюноджен, Инк. |
Неантагонистические egfr-связывающие молекулы и их иммуноконъюгаты
|
|
MX2013004761A
(es)
|
2010-10-29 |
2013-08-27 |
Immunogen Inc |
Nuevas moleculas de union al receptor del factor de crecimiento epidermico (egfr) e inmunoconjugados de estas.
|
|
MX2013005046A
(es)
*
|
2010-11-03 |
2013-12-12 |
Immunogen Inc |
Agentes citotoxicos que comprenden nuevos derivados de ansamitocina.
|
|
CN103313990B
(zh)
*
|
2010-11-17 |
2016-07-20 |
基因泰克公司 |
丙氨酰美登醇抗体偶联物
|
|
CN103260406B
(zh)
|
2010-12-09 |
2016-10-19 |
伊缪诺金公司 |
制备带电荷交联剂的方法
|
|
DK2675480T3
(en)
|
2011-02-15 |
2019-04-15 |
Immunogen Inc |
PROCEDURES FOR PREPARING CONJUGATES
|
|
WO2012122514A1
(en)
*
|
2011-03-09 |
2012-09-13 |
Centrose, Llc |
Extracellular targeted drug conjugates
|
|
MY171008A
(en)
|
2011-03-29 |
2019-09-23 |
Immunogen Inc |
Preparation of maytansinoid antibody conjugates by a one-step process
|
|
CN103717262B
(zh)
|
2011-03-29 |
2017-09-15 |
伊缪诺金公司 |
通过一步法制备类美登素抗体缀合物
|
|
BR112013025415B1
(pt)
|
2011-04-01 |
2021-03-16 |
Immunogen, Inc |
uso de um imunoconjugado antirreceptor de folato 1 (folr1)
|
|
WO2012138749A1
(en)
*
|
2011-04-04 |
2012-10-11 |
Immunogen, Inc. |
Methods for decreasing ocular toxicity of antibody drug conjugates
|
|
ME03071B
(me)
|
2011-04-21 |
2019-01-20 |
Bristol Myers Squibb Co |
Polipeptidi antitela koji antagonizuju cd40
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
TWI597065B
(zh)
|
2011-06-10 |
2017-09-01 |
梅爾莎納醫療公司 |
蛋白質－聚合物－藥物共軛體
|
|
US10300140B2
(en)
|
2011-07-28 |
2019-05-28 |
I2 Pharmaceuticals, Inc. |
Sur-binding proteins against ERBB3
|
|
MX2014006087A
(es)
|
2011-11-21 |
2014-08-01 |
Immunogen Inc |
Metodo de tratamiento de tumores que son resistentes a terapias contra el receptor del factor de crecimiento epidermico (egfr) con agentes citotoxicos conjugados con anticuerpos dirigidos contra el receptor del factor de crecimiento epidermico.
|
|
WO2013096828A1
(en)
|
2011-12-22 |
2013-06-27 |
Sea Lane Biotechnologies, Llc |
Surrogate binding proteins
|
|
RU2624731C2
(ru)
*
|
2012-01-27 |
2017-07-06 |
Ф. Хоффманн-Ля Рош Аг |
Конъюгаты антагонистов интегрина для нацеленной доставки к клеткам, экспрессирующим vla-4
|
|
US10080805B2
(en)
|
2012-02-24 |
2018-09-25 |
Purdue Research Foundation |
Cholecystokinin B receptor targeting for imaging and therapy
|
|
US20140080175A1
(en)
|
2012-03-29 |
2014-03-20 |
Endocyte, Inc. |
Processes for preparing tubulysin derivatives and conjugates thereof
|
|
MX362514B
(es)
|
2012-08-31 |
2019-01-22 |
Immunogen Inc |
Kits y ensayos de diagnostico para la deteccion del receptor 1 de folato.
|
|
MX359599B
(es)
|
2012-10-04 |
2018-09-12 |
Immunogen Inc |
Uso de una membrana de pvdf para purificar conjugados de agentes de unión celular y agentes citotóxicos.
|
|
US20150306242A1
(en)
*
|
2012-10-04 |
2015-10-29 |
Immunogen, Inc. |
Process for preparing stable antibody maytansinoid conjugates
|
|
IN2015DN04147A
(cg-RX-API-DMAC7.html)
|
2012-10-16 |
2015-10-16 |
Endocyte Inc |
|
|
NO2789793T3
(cg-RX-API-DMAC7.html)
*
|
2012-10-24 |
2018-01-27 |
|
|
|
IN2015DN02349A
(cg-RX-API-DMAC7.html)
*
|
2012-10-24 |
2015-08-28 |
Polytherics Ltd |
|
|
EP2922818B1
(en)
|
2012-11-24 |
2018-09-05 |
Hangzhou Dac Biotech Co., Ltd |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
|
WO2014089177A2
(en)
|
2012-12-04 |
2014-06-12 |
Massachusetts Institute Of Technology |
Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
|
|
CN103288957B
(zh)
|
2012-12-21 |
2015-01-28 |
百奥泰生物科技(广州)有限公司 |
一种抑制肿瘤生长的抗体药物衍生物及其制备方法和用途
|
|
CN104650113A
(zh)
*
|
2012-12-21 |
2015-05-27 |
百奥泰生物科技(广州)有限公司 |
类美登素衍生物及其制备方法和用途
|
|
US9968673B2
(en)
*
|
2013-02-26 |
2018-05-15 |
Commissariat á l'ènergie atomique et aux ènergies alternatives |
Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
|
|
FR3002454B1
(fr)
*
|
2013-02-26 |
2015-04-10 |
Commissariat Energie Atomique |
Composition immunogene sous forme d'emulsion
|
|
WO2014134483A2
(en)
*
|
2013-02-28 |
2014-09-04 |
Immunogen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
CN110143999B
(zh)
|
2013-03-15 |
2023-12-05 |
酵活英属哥伦比亚省公司 |
具细胞毒性和抗有丝分裂的化合物以及其使用方法
|
|
MY183572A
(en)
|
2013-03-15 |
2021-02-26 |
Regeneron Pharma |
Biologically active molecules, conjugates thereof, and therapeutic uses
|
|
MX370829B
(es)
*
|
2013-05-02 |
2020-01-08 |
Hoffmann La Roche |
Uso de un anticuerpo para cd20 afucosilado con un conjugado de anticuerpo para cd22-fármaco.
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
TWI641620B
(zh)
*
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗－ｐｒｌｒ抗體及其用途
|
|
CN105530942B
(zh)
|
2013-08-26 |
2019-10-11 |
瑞泽恩制药公司 |
一种包含大环内酯类非对映体的药物组合物、其制备方法和用途
|
|
PL3038650T3
(pl)
|
2013-08-30 |
2021-11-22 |
Immunogen, Inc. |
Przeciwciała i testy do wykrywania receptora folianu 1
|
|
SG10201801779XA
(en)
|
2013-09-05 |
2018-04-27 |
Jackson Lab |
Compositions for rna-chromatin interaction analysis and uses thereof
|
|
IL298044B2
(en)
|
2013-10-08 |
2024-11-01 |
Immunogen Inc |
Dosing regimens of anti-FOLR1 immunoconjugate
|
|
CN105813655B
(zh)
|
2013-10-11 |
2022-03-15 |
阿萨纳生物科技有限责任公司 |
蛋白-聚合物-药物缀合物
|
|
CN105979970B
(zh)
|
2013-10-11 |
2019-09-10 |
梅尔莎纳医疗公司 |
蛋白质-聚合物-药物共轭物
|
|
CN103483357B
(zh)
*
|
2013-10-12 |
2015-11-18 |
齐鲁制药有限公司 |
一种抗体-美登素偶联物的中间体新晶型及其制备方法
|
|
WO2015081857A1
(en)
*
|
2013-12-02 |
2015-06-11 |
Hong Kong Baptist University |
Anticancer maytansinoids with two fused macrocyclic rings
|
|
JP6560681B2
(ja)
|
2013-12-27 |
2019-08-14 |
ザイムワークス インコーポレイティド |
薬物結合体のためのスルホンアミド含有連結系
|
|
AU2015210578B2
(en)
*
|
2014-01-29 |
2020-04-16 |
Jiangsu Hengrui Medicine Co., Ltd. |
Ligand-cytotoxic drug conjugate, preparation method therefor, and uses thereof
|
|
MY178160A
(en)
|
2014-03-11 |
2020-10-06 |
Regeneron Pharma |
Anti-egfrviii antibodies and uses thereof
|
|
JP6805425B2
(ja)
|
2014-03-24 |
2020-12-23 |
ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク |
タグ付けされたヌクレオチドを製造するための化学的方法
|
|
EP3138568B1
(en)
*
|
2014-04-29 |
2019-04-17 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
New stable antibody-drug conjugate, preparation method therefor, and use thereof
|
|
CA2953371C
(en)
|
2014-06-30 |
2021-08-24 |
Tarveda Therapeutics, Inc. |
Targeted conjugates and particles and formulations thereof
|
|
DK3160513T3
(da)
|
2014-06-30 |
2020-04-06 |
Glykos Finland Oy |
Saccharidderivat af en toksisk payload og antistofkonjugater deraf
|
|
CA2958882A1
(en)
|
2014-09-02 |
2016-03-10 |
Immunogen, Inc. |
Methods for formulating antibody drug conjugate compositions
|
|
WO2016036804A1
(en)
|
2014-09-03 |
2016-03-10 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
|
EP3188733B1
(en)
*
|
2014-09-03 |
2019-11-06 |
ImmunoGen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
SG11201701455SA
(en)
|
2014-09-03 |
2017-03-30 |
Immunogen Inc |
Cytotoxic benzodiazepine derivatives
|
|
KR102494557B1
(ko)
|
2014-09-17 |
2023-02-02 |
자임워크스 비씨 인코포레이티드 |
세포독성 및 항유사분열성 화합물, 그리고 이를 이용하는 방법
|
|
MX386328B
(es)
|
2015-03-27 |
2025-03-18 |
Regeneron Pharma |
Derivados de maitansinoide, conjugados de los mismos, y metodos de uso.
|
|
SG10202110908WA
(en)
|
2015-05-04 |
2021-11-29 |
Cytomx Therapeutics Inc |
Anti-cd166 antibodies, activatable anti-cd166 antibodies, and methods of use thereof
|
|
US10449258B2
(en)
|
2015-06-09 |
2019-10-22 |
Xdcexplorer (Shanghai) Co., Ltd. |
Antibody drug conjugate, intermediate, preparation method, pharmaceutical composition and uses thereof
|
|
SI3313845T1
(sl)
|
2015-06-29 |
2021-01-29 |
Immunogen, Inc. |
Konjugati spremenjenih protiteles cisteina
|
|
JP6700321B2
(ja)
*
|
2015-07-04 |
2020-05-27 |
ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． |
細胞結合分子の特異的共役体
|
|
NZ737726A
(en)
|
2015-07-06 |
2023-03-31 |
Regeneron Pharma |
Multispecific antigen-binding molecules and uses thereof
|
|
AU2016297087B2
(en)
|
2015-07-21 |
2021-02-18 |
Immunogen, Inc |
Methods of preparing cytotoxic benzodiazepine derivatives
|
|
US10509035B2
(en)
|
2015-08-07 |
2019-12-17 |
Gamamabs Pharma Sa |
Antibodies, antibody drug conjugates and methods of use
|
|
KR102700777B1
(ko)
|
2015-09-17 |
2024-08-29 |
이뮤노젠 아이엔씨 |
항-folr1 면역접합체를 포함하는 치료제 조합
|
|
CA3001712A1
(en)
|
2015-10-28 |
2017-05-04 |
Tarveda Therapeutics, Inc. |
Sstr-targeted conjugates and particles and formulations thereof
|
|
CN108495619A
(zh)
|
2015-11-10 |
2018-09-04 |
儿研所儿童医学中心 |
棘霉素制剂及其制备方法和使用方法
|
|
PT3380525T
(pt)
|
2015-11-25 |
2024-02-05 |
Immunogen Inc |
Formulações farmacêuticas e métodos que as utilizam
|
|
CN108602890A
(zh)
|
2015-12-11 |
2018-09-28 |
瑞泽恩制药公司 |
用于减少或预防对egfr和/或erbb3阻滞剂具有抗性的肿瘤生长的方法
|
|
MX390630B
(es)
|
2016-01-25 |
2025-03-21 |
Regeneron Pharma |
Derivados de maitansinoide, conjugados de los mismos y metodos de uso.
|
|
RS62108B1
(sr)
*
|
2016-03-02 |
2021-08-31 |
Eisai R&D Man Co Ltd |
Antitelo-lek konjugati na bazi eribulina i postupci primene
|
|
US11603346B2
(en)
|
2016-03-07 |
2023-03-14 |
Hanmi Pharm. Co., Ltd. |
Polyethylene glycol derivative and use thereof
|
|
EP3448891A1
(en)
|
2016-04-28 |
2019-03-06 |
Regeneron Pharmaceuticals, Inc. |
Methods of making multispecific antigen-binding molecules
|
|
US10918627B2
(en)
|
2016-05-11 |
2021-02-16 |
Massachusetts Institute Of Technology |
Convergent and enantioselective total synthesis of Communesin analogs
|
|
CN109963870B
(zh)
|
2016-06-08 |
2023-07-28 |
艾伯维公司 |
抗b7-h3抗体和抗体药物偶联物
|
|
JP2019524687A
(ja)
|
2016-07-01 |
2019-09-05 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
抗体薬物複合体およびこれを用いた治療方法
|
|
RU2653443C2
(ru)
*
|
2016-07-15 |
2018-05-08 |
Закрытое Акционерное Общество "Биокад" |
Биспецифичные анти-her2/анти-her3 антитела
|
|
US10772972B2
(en)
|
2016-09-23 |
2020-09-15 |
Regeneron Pharmaceuticals, Inc. |
Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof
|
|
HRP20231281T1
(hr)
|
2016-09-23 |
2024-02-02 |
Regeneron Pharmaceuticals, Inc. |
Bispecifična anti-muc16-cd3 antitijela i konjugati anti-muc16 s lijekom
|
|
KR20190074310A
(ko)
|
2016-11-08 |
2019-06-27 |
리제너론 파마슈티칼스 인코포레이티드 |
스테로이드 및 이의 단백질-접합체
|
|
TWI782930B
(zh)
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
|
|
MA46887A
(fr)
|
2016-11-23 |
2019-10-02 |
Immunogen Inc |
Sulfonation sélective de dérivés de benzodiazépine
|
|
IL266917B2
(en)
|
2016-11-29 |
2023-10-01 |
Regeneron Pharma |
Anti-human prolactin receptor (prlr) antibody-drug conjugates and use thereof in combination therapy of prlr positive breast cancer
|
|
EP3554544A4
(en)
|
2016-12-16 |
2020-07-29 |
Bluefin Biomedicine, Inc. |
ANTI-PROTEIN 1 ANTIBODY CONTAINING AN ANTI-CUB DOMAIN (CDCP1), ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE
|
|
LT3558391T
(lt)
|
2016-12-23 |
2022-07-11 |
Immunogen, Inc. |
Imunokonjugatai, kurių taikinys yra adam9, ir jų naudojimo būdai
|
|
WO2018129029A1
(en)
|
2017-01-04 |
2018-07-12 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
US20200061031A1
(en)
|
2017-02-28 |
2020-02-27 |
Kinki University |
Method for treating egfr-tki-resistant non-small cell lung cancer by administration of anti-her3 antibody-drug conjugate
|
|
KR102681168B1
(ko)
|
2017-02-28 |
2024-07-04 |
이뮤노젠 아이엔씨 |
자기희생적 펩티드 링커 및 이들의 접합체를 갖는 메이탄시노이드 유도체
|
|
EP3381474A1
(en)
*
|
2017-03-27 |
2018-10-03 |
Alfasigma S.p.A. |
Histone deacetylase inhibitors-based antibody drug conjugates (adcs) and use in therapy
|
|
WO2018181059A1
(ja)
|
2017-03-30 |
2018-10-04 |
日油株式会社 |
ヘテロ二官能性単分散ポリエチレングリコール及びそれを用いた複合体
|
|
WO2018195243A1
(en)
|
2017-04-20 |
2018-10-25 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives and conjugates thereof
|
|
WO2018209239A1
(en)
|
2017-05-11 |
2018-11-15 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
|
JP7364471B2
(ja)
|
2017-05-18 |
2023-10-18 |
レゲネロン ファーマシューティカルス，インコーポレーテッド |
シクロデキストリンタンパク質薬物コンジュゲート
|
|
CN111065622A
(zh)
|
2017-05-18 |
2020-04-24 |
里珍纳龙药品有限公司 |
双八氢菲羧酰胺类化合物及其蛋白质偶联物
|
|
JP7348844B2
(ja)
|
2017-06-07 |
2023-09-21 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
内部移行酵素のための組成物および方法
|
|
CA3067311A1
(en)
*
|
2017-06-20 |
2018-12-27 |
Sorrento Therapeutics, Inc. |
Cd38 antibody drug conjugate
|
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
|
WO2019094395A2
(en)
|
2017-11-07 |
2019-05-16 |
Regeneron Pharmaceuticals, Inc. |
Hydrophilic linkers for antibody drug conjugates
|
|
CN109771658B
(zh)
*
|
2017-11-14 |
2021-12-10 |
博瑞生物医药（苏州）股份有限公司 |
靶向多臂偶联物
|
|
WO2019133652A1
(en)
|
2017-12-28 |
2019-07-04 |
Immunogen, Inc. |
Benzodiazepine derivatives
|
|
AU2019205542B2
(en)
|
2018-01-08 |
2025-10-23 |
Regeneron Pharmaceuticals, Inc. |
Steroids and antibody-conjugates thereof
|
|
CA3087993A1
(en)
*
|
2018-01-12 |
2019-07-18 |
Immunogen, Inc. |
Methods for antibody drug conjugation, purification, and formulation
|
|
AU2019262953B2
(en)
|
2018-04-30 |
2025-12-04 |
Regeneron Pharmaceuticals, Inc. |
Antibodies, and bispecific antigen-binding molecules that bind HER2 and/or APLP2, conjugates, and uses thereof
|
|
SG11202010909RA
(en)
|
2018-05-09 |
2020-12-30 |
Regeneron Pharma |
Anti-msr1 antibodies and methods of use thereof
|
|
US12252544B2
(en)
|
2018-05-17 |
2025-03-18 |
Regeneron Pharmaceuticals, Inc. |
Anti-CD63 antibodies, conjugates, and uses thereof
|
|
US20210275685A1
(en)
|
2018-06-26 |
2021-09-09 |
Immunogen, Inc. |
Immunoconjugates targeting adam9 and methods of use thereof
|
|
WO2020014306A1
(en)
|
2018-07-10 |
2020-01-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
TW202024133A
(zh)
|
2018-09-20 |
2020-07-01 |
日商第一三共股份有限公司 |
利用投予抗her3抗體-藥物結合物之her3突變癌之治療
|
|
CN109350748B
(zh)
*
|
2018-10-24 |
2021-06-11 |
沈阳药科大学 |
氧化还原双敏感键桥连小分子前药及其自组装纳米粒
|
|
TWI897855B
(zh)
|
2018-10-26 |
2025-09-21 |
美商免疫遺傳股份有限公司 |
Ｅ ｐ Ｃ Ａ Ｍ 抗體、可活化抗體及免疫偶聯物以及其用途
|
|
MA53455B1
(fr)
|
2018-11-20 |
2022-11-30 |
Regeneron Pharma |
Dérivés de bis-octahydrophénanthrène carboxamide et leurs conjugués protéiques destinés à être utilisés en tant qu'agonistes de lxr
|
|
SG11202106658XA
(en)
|
2018-12-21 |
2021-07-29 |
Regeneron Pharma |
Rifamycin analogs and antibody-drug conjugates thereof
|
|
EA202191769A1
(ru)
|
2018-12-21 |
2021-12-08 |
Регенерон Фармасьютикалз, Инк. |
Тубулизины и конъюгаты белок-тубулизин
|
|
KR20250156850A
(ko)
|
2019-01-08 |
2025-11-03 |
리제너론 파마슈티칼스 인코포레이티드 |
흔적이 없는 링커 및 이의 단백질-접합체
|
|
MX2021010114A
(es)
|
2019-02-21 |
2021-12-10 |
Regeneron Pharma |
Métodos para tratar el cáncer ocular mediante el uso de anticuerpos anti-met y moléculas de unión a antígeno bispecíficas que se unen a met.
|
|
JP7682798B2
(ja)
|
2019-03-20 |
2025-05-26 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
クローディン６抗体及び薬物複合体
|
|
JP7682797B2
(ja)
|
2019-03-20 |
2025-05-26 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
クローディン６二重特異性抗体
|
|
TW202102506A
(zh)
|
2019-03-29 |
2021-01-16 |
美商伊繆諾金公司 |
苯二氮平衍生物
|
|
EP4316524A3
(en)
|
2019-04-26 |
2024-04-24 |
ImmunoGen, Inc. |
Camptothecin derivatives
|
|
US11535634B2
(en)
|
2019-06-05 |
2022-12-27 |
Massachusetts Institute Of Technology |
Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
|
|
PE20220485A1
(es)
|
2019-07-10 |
2022-04-04 |
Cybrexa 3 Inc |
Conjugados peptidicos de agentes dirigidos a microtubulos como terapeuticos
|
|
PE20220563A1
(es)
|
2019-07-10 |
2022-04-13 |
Cybrexa 2 Inc |
Conjugados peptidicos de citotoxinas como terapeuticos
|
|
MX2022002886A
(es)
|
2019-09-16 |
2022-04-06 |
Regeneron Pharma |
Proteinas de union met radiomarcadas para la obtencion de imagenes por inmuno-pet.
|
|
US11814428B2
(en)
|
2019-09-19 |
2023-11-14 |
Regeneron Pharmaceuticals, Inc. |
Anti-PTCRA antibody-drug conjugates and uses thereof
|
|
CN115348874A
(zh)
|
2020-01-24 |
2022-11-15 |
里珍纳龙药品有限公司 |
蛋白质-抗病毒化合物偶联物
|
|
BR112022017064A2
(pt)
|
2020-02-25 |
2022-11-16 |
Mediboston Inc |
Derivados da camptotecina e seus conjugados
|
|
KR20220148200A
(ko)
|
2020-02-28 |
2022-11-04 |
리제너론 파마슈티칼스 인코포레이티드 |
Her2에 결합하는 이중특이적 항원 결합 분자 및 이의 사용 방법
|
|
US11701427B2
(en)
|
2020-04-16 |
2023-07-18 |
Regeneron Pharmaceuticals, Inc. |
Diels-alder conjugation methods
|
|
EP4171653A2
(en)
|
2020-06-24 |
2023-05-03 |
Regeneron Pharmaceuticals, Inc. |
Tubulysins and protein-tubulysin conjugates
|
|
EP4178624A2
(en)
|
2020-07-07 |
2023-05-17 |
Bionecure Therapeutics, Inc. |
Maytansinoids as adc payloads and their use for the treatment of cancer
|
|
AU2021308190A1
(en)
|
2020-07-13 |
2023-02-02 |
Regeneron Pharmaceuticals, Inc. |
Camptothecin analogs conjugated to a glutamine residue in a protein, and their use
|
|
BR112023000711A2
(pt)
|
2020-07-17 |
2023-01-31 |
Daiichi Sankyo Co Ltd |
Método para produzir uma composição de conjugado de anticorpo-fármaco, e, composição de conjugado de anticorpo-fármaco
|
|
KR20230070337A
(ko)
|
2020-09-14 |
2023-05-22 |
리제너론 파마슈티칼스 인코포레이티드 |
Glp1 펩티도미메틱을 포함하는 항체-약물 접합체 및 이의 용도
|
|
CN116406379A
(zh)
|
2020-10-22 |
2023-07-07 |
瑞泽恩制药公司 |
抗fgfr2抗体和其使用方法
|
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
US12030888B2
(en)
|
2021-02-24 |
2024-07-09 |
Massachusetts Institute Of Technology |
Himastatin derivatives, and processes of preparation thereof, and uses thereof
|
|
US20220378929A1
(en)
|
2021-02-25 |
2022-12-01 |
MediBoston Limted |
Anti-her2 antibody-drug conjugates and uses thereof
|
|
EP4304658A4
(en)
|
2021-03-08 |
2025-03-12 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
Antibody-immunagonist conjugate and applications thereof
|
|
WO2022218331A1
(en)
|
2021-04-14 |
2022-10-20 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
Linkers, conjugates and applications thereof
|
|
JP2024529960A
(ja)
|
2021-07-28 |
2024-08-14 |
レゲネロン ファーマシューティカルス，インコーポレーテッド |
タンパク質－抗ウイルス化合物コンジュゲート
|
|
JP2024534101A
(ja)
*
|
2021-08-20 |
2024-09-18 |
プサン ナショナル ユニバーシティ インダストリー － ユニバーシティ コーポレイション ファンデーション |
オブジェクトが固定された膨潤性高分子の製造方法
|
|
US12377157B2
(en)
|
2021-12-15 |
2025-08-05 |
The Administrators Of The Tulane Educational Fund |
Conjugates, their compositions, and their related methods
|
|
WO2023129518A1
(en)
|
2021-12-29 |
2023-07-06 |
Regeneron Pharmaceuticals, Inc. |
Tubulysins and protein-tubulysin conjugates
|
|
MX2024008640A
(es)
|
2022-01-12 |
2024-07-24 |
Regeneron Pharma |
Analogos de camptotecina conjugados a un residuo de glutamina en una proteina y su uso.
|
|
MX2024008361A
(es)
|
2022-01-14 |
2024-09-10 |
Regeneron Pharma |
Derivados de verrucarina a y conjugados anticuerpo-fármaco de los mismos.
|
|
JP2025512735A
(ja)
|
2022-03-11 |
2025-04-22 |
リジェネロン ファーマシューティカルズ，インク． |
Ｇｌｐ１ペプチド模倣体を含む抗ｇｌｐ１ｒ抗体係留型薬物コンジュゲートおよびその使用
|
|
CN120239705A
(zh)
|
2022-07-21 |
2025-07-01 |
萤火虫生物股份有限公司 |
糖皮质激素受体激动剂和其缀合物
|
|
US20240108744A1
(en)
|
2022-07-27 |
2024-04-04 |
Mediboston Limited |
Auristatin derivatives and conjugates thereof
|
|
KR20250128394A
(ko)
|
2022-11-30 |
2025-08-27 |
리제너론 파마슈티칼스 인코포레이티드 |
Tlr7 작용제 및 이의 항체-약물-접합체
|
|
AU2023407365A1
(en)
|
2022-12-21 |
2025-07-31 |
Regeneron Pharmaceuticals, Inc. |
Prodrugs of topoisomerase i inhibitor for adc conjugations and methods of use thereof
|
|
CN121001751A
(zh)
|
2023-02-09 |
2025-11-21 |
里珍纳龙药品有限公司 |
借助逆电子需求狄尔斯-阿尔德反应的抗体-药物缀合物
|
|
WO2024220628A1
(en)
*
|
2023-04-18 |
2024-10-24 |
The Regents Of The University Of Colorado, A Body Corporate |
Target for combatting the foreign body response to implantable biomaterials
|
|
WO2024229105A1
(en)
|
2023-05-02 |
2024-11-07 |
Regeneron Pharmaceuticals, Inc. |
Anti-human m-cadherin (cdh15) antibodies, conjugates, and uses thereof for delivery of genetic payloads to muscle cells
|
|
CN121219016A
(zh)
|
2023-06-02 |
2025-12-26 |
第一三共株式会社 |
抗-her3抗体-药物缀合物和rasg12c抑制剂的组合
|
|
WO2025014533A1
(en)
|
2023-07-10 |
2025-01-16 |
Regeneron Pharmaceuticals, Inc. |
Anti-human cacng1 antibody-drug conjugates and uses thereof
|
|
WO2025094146A1
(en)
|
2023-11-02 |
2025-05-08 |
Immunogen Switzerland Gmbh |
Vasconstrictors for reducing ocular toxicity of antibody-maytansinoid conjugates
|
|
WO2025096921A1
(en)
|
2023-11-03 |
2025-05-08 |
Regeneron Pharmaceuticals, Inc. |
Peptide acids as a glp1r agonist and antibody-drug conjugates thereof
|
|
WO2025117727A1
(en)
|
2023-11-29 |
2025-06-05 |
Regeneron Pharmaceuticals, Inc. |
Analogs of quinoxaline/quinoline cytotoxins, linker- payloads, protein-drug conjugates, and uses thereof
|
|
CN118580194A
(zh)
*
|
2024-05-21 |
2024-09-03 |
南方科技大学 |
一种双功能分子探针的制备方法
|